Filing Details
- Accession Number:
- 0001628280-25-012680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-13 17:26:25
- Reporting Period:
- 2025-03-11
- Filing Date:
- 2025-03-13
- Accepted Time:
- 2025-03-13 17:26:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 834365 | Biolife Solutions Inc | BLFS | Electromedical & Electrotherapeutic Apparatus (3845) | 943076866 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1837756 | Sarah Aebersold | 3303 Monte Villa Parkway Suite 310 Bothell WA 98021 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-11 | 1,091 | $25.00 | 58,816 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-12 | 7,324 | $26.34 | 51,492 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
- The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-11-2024.
Billionaire Hedge Funds
